Dr. Alan L. Robin was the first Executive Vice President of the American Glaucoma Society from 2018-2023. He is a leader in the clinical management and scientific study of glaucoma. Dr. Robin holds joint emeritus Associate Professorships in Ophthalmology and in International Health at the Johns Hopkins University and is also a Professor at the University of Michigan. He was formerly a Professor of Ophthalmology in the VA system, as well as co-director of the Glaucoma Service at the Greater Baltimore Medical Center. Dr. Robin held an active private practice with offices in the Baltimore and southern Pennsylvania areas.

Dr. Robin attended Yale University and Tufts University School of Medicine. He completed his fellowship at the Wilmer Institute. He was a HEED fellow and a recipient of two NIH RO1 grants as well as an award from the Glaucoma Research Foundation. He has been an active clinical investigator in initial studies of widely used glaucoma medications including apraclonidine, latanoprost, brimonidine, brinzolamide, and rho kinase inhibitors. He was the principal investigator and developed Nd:YAG laser iridotomy, responsible for the development of alpha-agonists for clinical use, and performed the first modern prevalence study in India. Dr. Robin has published almost 300 peer-reviewed seminal articles on the use of lasers, drugs, and surgery for glaucoma treatments in addition to manuscripts on cost effectiveness and adherence.

His current research interests include pseudoexfoliation, medical waste, screening and detecting treatable eye diseases, and improving adherence to glaucoma therapies. He is one of the most knowledgeable ophthalmologists on adherence. Dr. Robin has authored or co-authored almost 300 peer-reviewed papers, 24 book chapters, and given well over 100 invited lectures on all continents. He has won many honors and awards during his career, among them the Senior Honor and Secretariat awards of the AAO, the Outstanding Humanitarian Service award of the AAO and the American Glaucoma Society, the silver achievement award of the Associate of Ophthalmology and Visual Sciences, and the American Glaucoma Society President’s award.

Dr. Robin has made over 100 trips to India and Nepal since the 1980s and worked closely with Dr. Ruit (founder of Tilganga Eye Institute) in Kathmandu and Dr. Venkataswamy (founder of the Aravind Eye Institute). He was instrumental in the development of the Tilganga Eye Center in Kathmandu, Nepal, and published the first paper documenting the value of intraocular lenses in the developing world. At the Aravind Eye Institute he was instrumental in establishing its glaucoma service and still serves as its co-director. He is an honorary member of both the Indian Glaucoma Society and Nepalese Glaucoma Society.